Glenmark Pharmaceuticals recalls 6,528 US bottles of high blood pressure drug Diltiazem Hydrochloride due to failed dissolution standards, per the US FDA.

Glenmark Pharmaceuticals recalls 6,528 bottles of a high blood pressure medication in the US market due to failed dissolution specifications, according to the US Food and Drug Administration (FDA). The affected lot of Diltiazem Hydrochloride extended-release capsules, produced in India, is being recalled by New Jersey-based Glenmark Pharmaceuticals Inc. The Class II recall was initiated on March 26.